doi: 10.1111/all.14774.
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines
Affiliations
- PMID: 34128559
- PMCID: PMC8441744
- DOI: 10.1111/all.14774
Item in Clipboard
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines
Allergy.
2021 Jun.
No abstract available
Conflict of interest statement
The authors have no conflicts of interest to declare.
Comment in
-
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines".Allergy. 2021 Jun;76(6):1943-1944. doi: 10.1111/all.14761. Allergy. 2021. PMID: 34128563 Free PMC article. No abstract available.
Similar articles
-
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines".Allergy. 2021 Jun;76(6):1943-1944. doi: 10.1111/all.14761. Allergy. 2021. PMID: 34128563 Free PMC article. No abstract available.
-
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2. J Investig Allergol Clin Immunol. 2021. PMID: 33648905 Clinical Trial. No abstract available.
-
Vaccine allergy: evidence to consider for COVID-19 vaccines.Curr Opin Allergy Clin Immunol. 2021 Aug 1;21(4):401-409. doi: 10.1097/ACI.0000000000000762. Curr Opin Allergy Clin Immunol. 2021. PMID: 34091550 Free PMC article. Review.
-
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.Vaccine. 2023 Jul 19;41(32):4693-4699. doi: 10.1016/j.vaccine.2023.06.039. Epub 2023 Jun 15. Vaccine. 2023. PMID: 37349223 Free PMC article.
-
Allergy to COVID-19 vaccines: A current update.Allergol Int. 2021 Jul;70(3):313-318. doi: 10.1016/j.alit.2021.04.003. Epub 2021 Apr 23. Allergol Int. 2021. PMID: 33962863 Free PMC article. Review.
Cited by
-
SARS-CoV-2 vaccines-induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?Rev Saude Publica. 2021 Oct 29;55:70. doi: 10.11606/s1518-8787.2021055003855. eCollection 2021. Rev Saude Publica. 2021. PMID: 34730750 Free PMC article.
-
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study.Vaccines (Basel). 2024 Sep 17;12(9):1059. doi: 10.3390/vaccines12091059. Vaccines (Basel). 2024. PMID: 39340089 Free PMC article.
-
Global Burden of Vaccine-Associated Chronic Urticaria, 2010-2023: From the Global Pharmacovigilance Database.Allergy Asthma Immunol Res. 2024 Nov;16(6):613-625. doi: 10.4168/aair.2024.16.6.613. Allergy Asthma Immunol Res. 2024. PMID: 39622686 Free PMC article.
-
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review.Vaccines (Basel). 2022 Sep 1;10(9):1445. doi: 10.3390/vaccines10091445. Vaccines (Basel). 2022. PMID: 36146523 Free PMC article. Review.
-
SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity.Front Allergy. 2022 Dec 20;3:1046545. doi: 10.3389/falgy.2022.1046545. eCollection 2022. Front Allergy. 2022. PMID: 36606064 Free PMC article.
References
-
- Cabanillas B, Akdis C, Novak N. Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol? Allergy. 202176(6):1621‐1623. - PubMed
-
- Evans RK, Nawrocki DK, Isopi LA, et al. Development of stable liquid formulations for adenovirus‐based vaccines. J Pharm Sci. 2004;93:2458‐2475. - PubMed
-
- Lukawska J, Mandaliya D, Chan AE, et al. Anaphylaxis to trometamol excipient in gadolinium‐based contrast agents for clinical imaging. J Allergy Clin Immunol Pract. 2019;7:1086‐1087. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
